Clinical trial

Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage…

NCT00077064 · Radiation Therapy Oncology Group, Other · Terminated

Key facts

NCT number NCT00077064
Title Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
Official title A Phase II Randomized Trial With Captopril In Patients Who Have Received Radiation Therapy +/- Chemotherapy For Stage II-IIIB Non-Small Cell Lung Cancer, Stage I Central Non-Small Cell Lung Cancer, Or Limited-Stage Small-Cell Lung Cancer
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH NRG Oncology
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Lung Cancer, Pulmonary Complications, Radiation Fibrosis
Intervention type Drug
Interventions captopril
Enrollment 81
Start date Jun 1, 2003
Primary completion Nov 1, 2008
Completion Dec 1, 2016
First posted Feb 11, 2004
Last update posted Mar 8, 2018
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies